Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Pyrogen Testing Market: By Product & Service, By Test Type, By End-User and Geography
Pyrogen Testing Market: By Product & Service, By Test Type, By End-User and Geography
Pyrogen Testing Market size is estimated to be valued at US$ 1,458.3 million in 2023 and is poised to grow at a significant CAGR of 12.5% over 2024-2030. Pyrogen testing is essential in modern healthcare since it detects the presence of pyrogen in an organism that causes fever. Pyrogen can be present in lipopolysaccharides and lipoteichoic acid. Contaminated pyrogenic can cause severe harmful consequences in the human body, such as fever. Based on product and service, the pyrogen testing market is segmented into assays, kits & reagents, instruments, and services.
The assays, kits, and reagents category held the most significant proportion of the pyrogen testing market. The growing demand for kit-based testing and the frequent need for immunoassays, kits, and reagents in large quantities as opposed to equipment are the primary reasons driving the expansion of this category. Moreover, market players are focusing on launching new products, acquisitions, and collaboration. For instance, Lonza, a multinational manufacturing company for pharmaceutical & biotechnology, Launches the Pyro Cell Monocyte Activation Test System for reliable and sustainable in vitro pyrogen testing. The growing pharmaceutical, biotechnology, and medical devices industries, increased R&D investment, and favorable government policies are some drivers driving the global pyrogen testing market in the forecasting period.
Study Period
2024-2030Base Year
2023CAGR
12.5%Largest Market
Asia PacificFastest Growing Market
North America
The rising frequency of major infectious diseases and epidemics has resulted in a continuous increase in demand for pyrogen testing procedures over the last decade. The market for pyrogen testing techniques (used for endotoxin and microbiological identification) is predicted to rise throughout the forecast period due to infectious diseases worldwide. Endotoxin detection products can help with infectious disease management, especially in places with inadequate healthcare facilities. Moreover, the recent outbreak of the coronavirus disease has created destruction in several nations across the globe.
The Pyrogen Testing market in North America is likely to hold the highest revenue share in 2021, and the same trend is expected over the forecast period due to the increased biopharmaceutical and pharmaceutical research spending, growing medication approvals, expanding pharmaceutical drug pipelines, and rising consumer knowledge regarding product safety. the Asia Pacific area is expected to have the most anticipated growth rate during the forecasting period due to rapid growth in emerging countries such as India, China, and Japan.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1,458.3 million |
|
Market CAGR |
12.5% |
|
By Product & Service |
|
|
By Test Type |
|
|
By End User |
|
Download Free Sample Report
Recent key trends affecting the pyrogen testing market are the spread of COVID-19, rising vaccine development focus, and rapid biotechnology and biopharmaceutical industry growth.
The Global Pyrogen Testing Market is anticipated to Witness a CAGR of 12.5% During the Forecast Period of 2022 to 2028.
The key Players Operating in the Global Pyrogen Testing Market are Merck Animal Health, Ceva Sante Animals, Vetoquinol S.A., Zoetis, Boehringer Ingelheim GmbH, Elanco, IDEXX, Heska Corporation, Covetous, DRE Veterinary, Mars Inc, Virbac, Televet, Phibro Animal Health Corporation, B. Braun Vet Care.
| 1.Executive Summary |
| 2.Global Pyrogen Testing Market Introduction |
| 2.1.Global Pyrogen Testing Market - Taxonomy |
| 2.2.Global Pyrogen Testing Market - Definitions |
| 2.2.1.By Product & Service |
| 2.2.2.By Test Type |
| 2.2.3.By End User |
| 2.2.4.Region |
| 3.Global Pyrogen Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Pyrogen Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Pyrogen Testing Market By By Product & Service, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Assays, Kits, & Reagents |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Services |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Pyrogen Testing Market By By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. LAL Tests |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Chromogenic Tests |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Turbidimetric Tests |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Gel Clot Tests |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. In Vitro Tests |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Rabbit Tests |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 7.Global Pyrogen Testing Market By By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Pharmaceutical & Biotechnology Companies |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Medical Device Companies |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Other End Users |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Pyrogen Testing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Pyrogen Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. By Product & Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Assays, Kits, & Reagents |
| 9.1.2.Instruments |
| 9.1.3.Services |
| 9.2. By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.LAL Tests |
| 9.2.2.Chromogenic Tests |
| 9.2.3.Turbidimetric Tests |
| 9.2.4.Gel Clot Tests |
| 9.2.5.In Vitro Tests |
| 9.2.6.Rabbit Tests |
| 9.3. By End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Pharmaceutical & Biotechnology Companies |
| 9.3.2.Medical Device Companies |
| 9.3.3.Other End Users |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Pyrogen Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. By Product & Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Assays, Kits, & Reagents |
| 10.1.2.Instruments |
| 10.1.3.Services |
| 10.2. By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.LAL Tests |
| 10.2.2.Chromogenic Tests |
| 10.2.3.Turbidimetric Tests |
| 10.2.4.Gel Clot Tests |
| 10.2.5.In Vitro Tests |
| 10.2.6.Rabbit Tests |
| 10.3. By End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Pharmaceutical & Biotechnology Companies |
| 10.3.2.Medical Device Companies |
| 10.3.3.Other End Users |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Pyrogen Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. By Product & Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Assays, Kits, & Reagents |
| 11.1.2.Instruments |
| 11.1.3.Services |
| 11.2. By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.LAL Tests |
| 11.2.2.Chromogenic Tests |
| 11.2.3.Turbidimetric Tests |
| 11.2.4.Gel Clot Tests |
| 11.2.5.In Vitro Tests |
| 11.2.6.Rabbit Tests |
| 11.3. By End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Pharmaceutical & Biotechnology Companies |
| 11.3.2.Medical Device Companies |
| 11.3.3.Other End Users |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Pyrogen Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. By Product & Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Assays, Kits, & Reagents |
| 12.1.2.Instruments |
| 12.1.3.Services |
| 12.2. By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.LAL Tests |
| 12.2.2.Chromogenic Tests |
| 12.2.3.Turbidimetric Tests |
| 12.2.4.Gel Clot Tests |
| 12.2.5.In Vitro Tests |
| 12.2.6.Rabbit Tests |
| 12.3. By End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Pharmaceutical & Biotechnology Companies |
| 12.3.2.Medical Device Companies |
| 12.3.3.Other End Users |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Pyrogen Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. By Product & Service Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Assays, Kits, & Reagents |
| 13.1.2.Instruments |
| 13.1.3.Services |
| 13.2. By Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.LAL Tests |
| 13.2.2.Chromogenic Tests |
| 13.2.3.Turbidimetric Tests |
| 13.2.4.Gel Clot Tests |
| 13.2.5.In Vitro Tests |
| 13.2.6.Rabbit Tests |
| 13.3. By End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Pharmaceutical & Biotechnology Companies |
| 13.3.2.Medical Device Companies |
| 13.3.3.Other End Users |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Charles River Laboratories, Inc. (US) |
| 14.2.2.Lonza (Switzerland) |
| 14.2.3.Merck KGaA (Germany) |
| 14.2.4.Thermo Fisher Scientific, Inc. (US) |
| 14.2.5.Associates of Cape Cod, Inc. (US) |
| 14.2.6.GenScript Biotech Corporation (China) |
| 14.2.7.bioMrieux SA (France) |
| 14.2.8.Eurofins Scientific (Luxembourg) |
| 14.2.9.WuXi AppTec (China) |
| 14.2.10.Hycult Biotech (Netherlands) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.